Quantification of Isradipine in Human Plasma Using LC-MS/MS for Pharmacokinetic and Bioequivalence Study
Document Type
Article
Publication Date
1-1-2009
Description
A highly sensitive and rapid method for the analysis of isradipine in human plasma using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) was developed. The procedure involves a simple liquid-liquid extraction of isradipine and amlodipine (IS, internal standard) with methyl-t-butyl ether after alkaline treatment and separation by RP-HPLC. Detection was performed by positive ion electrospray ionization (ESI) in multiple reaction monitoring (MRM) mode, monitoring the transitions m/z 372.1 → m/z 312.2 and m/z 408.8 → m/z 237.9, for quantification of isradipine and IS, respectively. The standard calibration curves showed good linearity within the range of 10 to 5000 pg/mL (r2 ≥ 0.9998). The lower limit of quantitation (LLOQ) was 10 pg/mL. The retention times of isradipine (0.81 min) and IS (0.65 min) suggested the potential for high throughput of the proposed method. In addition, no significant metabolic compounds were found to interfere with the analysis. This method offered good precision and accuracy and was successfully applied for the pharmacokinetic and bioequivalence studies of 5 mg of sustained-release isradipine in 24 healthy Korean volunteers.
Citation Information
Park, Jin H.; Park, Yoo Sin; Rhim, Si Y.; Jhee, Ok H.; Kim, Shin H.; Yang, Seok C.; Lee, Min H.; Shaw, Leslie M.; and Kang, Ju S.. 2009. Quantification of Isradipine in Human Plasma Using LC-MS/MS for Pharmacokinetic and Bioequivalence Study. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. Vol.877(1-2). 59-64. https://doi.org/10.1016/j.jchromb.2008.11.021 PMID: 19041284 ISSN: 1570-0232